Specifically, a study in obese patients with dysregulated type 2 diabetes found that 8 weeks of intervention with liraglutide 1.2 mg/daily significantly reduced sCD163 levels [19]. The gene discussed is CD163; the disease is type 2 diabetes mellitus.